Advertisement

Pharmacy World and Science

, Volume 16, Issue 1, pp 29–31 | Cite as

Clinical pharmacological studies on furosemide

With special emphasis on the use of high doses
  • Joseph J. M. van Meyel
Doctoral Theses

Conclusion

Within a population of patients with congestive heart failure (NYHA class III–IV), pharmacokinetics and pharmacodynamics of furosemide are hardly influenced by the state of compensation (in terms of presence or absence of massive edema). High dose furosemide (more than 1,000 mg a day) can be effective in the treatment of patients with refractory congestive heart failure as well as in the management of haemodialysis patients with residual diuresis. Continuous infusion is the most efficient and effective mode of furosemide administration (in healthy volunteers). Continuous infusion of furosemide is effective in the treatment of patients with refractory congestive heart failure. Furosemide treatment with a maximal infusion rate of 160 mg/h can be given safely under careful clinical and electrolyte control.

Keywords

Absorption Administration, oral Dosage Furosemide Heart failure, congestive Hemodialysis Infusions, intravenous Pharmacokinetics 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1994

Authors and Affiliations

  • Joseph J. M. van Meyel
    • 1
  1. 1.Department of Internal DiseasesUniversity Hospital NijmegenHB, Nijmegenthe Netherlands

Personalised recommendations